indicators

Gain Therapeutics Achieves Remarkable Breakthrough in Parkinson’s Disease Research

Source Node:
Time Stamp: August 29, 2023 8:20 AM - Modified On: August 29, 2023 - Published By:
Source Cluster:
Republished By Plato

Gain Therapeutics, Inc. (Nasdaq: GANX), a pioneering biotechnology company specializing in innovative allosteric small molecule therapies, has made significant strides in the fight against Parkinson's disease (PD). The Company's lead drug candidate, GT-02287, has demonstrated extraordinary potential in mitigating the effects of Parkinson's disease across two distinct preclinical models of the ailment. These findings suggest that GT-02287 has the capacity to alleviate Parkinson's disease pathology and enhance motor function. A notable highlight is the substantial reduction of plasma Neurofilament Light Chain (NfL) levels, an emerging biomarker for neurodegeneration. This advancement

Is the Future Digital?

Source Node:
Time Stamp: December 8, 2022 4:16 AM - Modified On: December 8, 2022 - Published By:
Source Cluster:
Republished By Plato

These days you can’t scroll through YouTube without encountering videos foretelling the end of crypto and the collapse of the global financial system. The clickbait culture that invaded traditional journalism has now spread to citizen journalism too, but how realistic are all of these dramatic claims? Fear, uncertainty, and doubt (FUD) pervade the mainstream media. So much so that even people with little knowledge of the technology claim it’s all going to zero. If you’re looking for bottom signals this is the equivalent of everyone FOMOing in at the top.